
|Videos|June 6, 2017
Jennifer Wenzel on Prioritizing Representation in Clinical Trials
Author(s)Jennifer Wenzel, PhD, RN, CCM, FAAN
Jennifer Wenzel, PhD, RN, CCM, FAAN, discusses why representation in clinical trials is not successful as an afterthought.
Advertisement
Jennifer Wenzel, PhD, RN, CCM, FAAN, of Johns Hopkins University School of Medicine, discusses why representation in clinical trials is not successful as an afterthought.
As funding for research gets tighter, there are less programs to ensure diversity in research — these are often the first programs to be cut when money is short. In response, nurses can advocate for funding and policies which allow for research promoting diversity. The only way to be sure that clinical trials have adequate representation is to make it a priority within research planning.
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Tentative Approval to Generic Olaparib Tablets
2
GU Oncology Trial Logistics: Nursing Insights from Dana-Farber
3
Study Reports 10-Year Outcomes of Focal Therapy for Prostate Cancer
4
Optimizing Multiple Myeloma Care: Insights From a Nursing Expert
5























































